Lewis Karen

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 43% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lewis Karen's trades of Apellis Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
63.69
Quantity 4,286
Value US$272,975
Transaction date
Proposed sale
Price
65.00
Quantity 1,738
Value US$112,963
Transaction date
Proposed sale
Price
65.58
Quantity 3,276
Value US$214,840
Transaction date
Proposed sale
Price
66.81
Quantity 1,632
Value US$109,032
Transaction date
Proposed sale
Price
86.00
Quantity 5,000
Value US$430,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-30 2025-01-29
S Sale
92,406 -4.6%
76.85
US$212,404 		92,406 -4.6% 76.85 US$212,404
2025-01-29 2025-01-29
PrS Proposed sale
76,504
190.18
US$1,250,675 		76,504 190.18 US$1,250,675
2025-01-23 2025-01-22
S Sale
51,584 -23.1%
113.47
US$1,116,379 		51,584 -23.1% 113.47 US$1,116,379
2025-01-22 2025-01-22
PrS Proposed sale
1,751
30.43
US$53,275 		1,751 30.43 US$53,275
2025-01-21 2025-01-17
S Sale
1,241 -2.8%
29.96
US$37,178 		1,241 -2.8% 29.96 US$37,178
2025-01-17 2025-01-17
PrS Proposed sale
1,241
29.96
US$37,178 		1,241 29.96 US$37,178
2025-01-14 2025-01-13
S Sale
1,599 -3.4%
28.70
US$45,895 		1,599 -3.4% 28.70 US$45,895
2025-01-13 2025-01-13
PrS Proposed sale
1,627
28.70
US$46,689 		1,627 28.70 US$46,689
2024-01-31 2024-01-30
PlS Planned sale
883 -1.9%
65.53
US$57,863 		883 -1.9% 65.53 US$57,863
2024-01-30 2024-01-30
PrS Proposed sale
883
65.53
US$57,863 		883 65.53 US$57,863
2024-01-31 2024-01-29
S Sale
367 -0.8%
64.14
US$23,539 		367 -0.8% 64.14 US$23,539
2024-01-29 2024-01-29
PrS Proposed sale
367
64.14
US$23,539 		367 64.14 US$23,539
2024-01-24 2024-01-23
PlS Planned sale
4,286 -8.3%
63.69
US$272,975 		4,286 -8.3% 63.69 US$272,975
2024-01-23 2024-01-23
PrS Proposed sale
4,286
63.69
US$272,975 		4,286 63.69 US$272,975
2024-01-23 2024-01-22
S Sale
1,738 -3.2%
65.00
US$112,963 		1,738 -3.2% 65.00 US$112,963
2024-01-22 2024-01-22
PrS Proposed sale
1,738
65.00
US$112,963 		1,738 65.00 US$112,963
2024-01-18 2024-01-17
PlS Planned sale
3,276 -5.8%
65.58
US$214,840 		3,276 -5.8% 65.58 US$214,840
2024-01-17 2024-01-17
PrS Proposed sale
3,276
65.58
US$214,840 		3,276 65.58 US$214,840
2024-01-17 2024-01-16
S Sale
1,632 -2.8%
66.81
US$109,032 		1,632 -2.8% 66.81 US$109,032
2024-01-16 2024-01-16
PrS Proposed sale
1,632
66.81
US$109,032 		1,632 66.81 US$109,032
2023-06-02 2023-06-01
PlS Planned sale
5,000 -10.8%
86.00
US$430,000 		5,000 -10.8% 86.00 US$430,000
2023-06-01 2023-06-01
PrS Proposed sale
5,000
86.00
US$430,000 		5,000 86.00 US$430,000
2023-04-05 2023-04-03
PlS Planned sale
5,000 -10.8%
75.00
US$375,000 		5,000 -10.8% 75.00 US$375,000
2023-02-27 2023-02-23
PlS Planned sale
1,104 -2.6%
68.76
US$75,911 		1,104 -2.6% 68.76 US$75,911
2023-01-31 2023-01-30
PlS Planned sale
883 -2.4%
52.76
US$46,587 		883 -2.4% 52.76 US$46,587
2023-01-25 2023-01-23
PlS Planned sale
2,955 -7.3%
51.58
US$152,419 		2,955 -7.3% 51.58 US$152,419